| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8773734 | Kidney International Reports | 2018 | 6 Pages |
Abstract
Among these patients, lower initial eGFR and dialysis dependence at presentation might increase the risk for ESRD. Immunosuppression did not affect renal outcomes in this sample of patients but was associated with a reduced risk for vasculitis relapse. More information is needed on factors that predict treatment response in this high-risk group.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Tessa K. Novick, Min Chen, Jennifer Scott, Frank B. Cortazar, Isabelle Ayoub, Mark A. Little, Zdenka Hruskova, Alan D. Salama, Christian Pagnoux, Duvuru Geetha,